SlideShare ist ein Scribd-Unternehmen logo
1 von 139
Downloaden Sie, um offline zu lesen
Interpretation of Arterial Blood Gases
Traditional Vs Modern

By

Gamal Rabie Agmy , MD , FCCP

Professor of Chest Diseases ,Assiut University
Handerson Hasselbach
Equation
•
•
•
•
•
•

PH= pKa+ Log HCO3/PaCo2
PH= Log HCO3/PaCo2
PH=  HCO3
PH=  HCO3
 PH=  PaCo2
PH=  PaCo2
Co2+H2o=H2co3=Hco3- + H+

Hprotein=H+ + Protein-
Normal Values
• PH
7.35-7.45
• HCO3 22-26 mEq/L
• PaCo2 35-45 mmHg
• PaO2 97 mmHg
• BE/BD +2 to -2
• Haemoglobin 15 gram
• A-a O2 gradient N < 15
A-a O2 gradient OLDER PERSONS

– 2.5 +0.25*AGE
– eg. AGE 60, 2.5+15=17.5
– eg. AGE 80, 2.5+20=22.5
Definition of Respiratory Failure

Respiratory failure is a syndrome of
inadequate gas exchange due to
dysfunction of one or more essential
components of the respiratory system
Types of Respiratory Failure
Type 1 (Hypoxemic ): * PO2 < 60 mmHg on room air.
Type 2 (Hypercapnic / Ventilatory): *PCO2 > 50
mmHg

Type 3 (Peri-operative): *This is generally a subset of
type 1 failure but is sometimes considered
separately because it is so common.
Type 4 (Shock): * secondary to cardiovascular
instability.
FIO2

Ventilation
without
perfusion
(deadspace
ventilation)

Hypoventilation

Diffusion
abnormality
Normal
Perfusion
without
ventilation
(shunting)
Brainstem

Airway

Lung

Spinal cord
Nerve root

Nerve

Pleura

Chest wall

Neuromuscular
junction
Respiratory
muscle

Sites at which disease may cause ventilatory disturbance
Types of RF:
• Type 1:
A-Acute
B-Chronic
C-Acute on top of chronic

• Type 2:
A-Acute
B-Chronic
C-Acute on top of chronic
Types of RF:
• Type 1:
PaO2<60 mm Hg
PaCo235-45 mmHg

• Type 2:
PaO2<60 mm Hg
PaCo2>50 mmHg
Types of RF:
Type 1:
• Acute:
Pao2<60mmHg
PaCo235-45mmHg

HCO3 Normal
PH > 7.45

• Chronic:
Pao2<60mmHg
HCO3 <22mEq/L

PaCo235-45mmHg
PH=7.40-7.45

• Acute on top of chronic:
Pao2<60mmHg
PaCo235-45mmHg

HCO3 <22mEq/L
PH > 7.45
Types of RF:
Type 2:
• Acute:
Pao2<60mmHg
PaCo2>50 mmHg

HCO3 Normal
PH<7.35

• Chronic:
Pao2<60mmHg
HCO3 >26 mEq/L

PaCo2 >50 mmHg
PH=7.35-7.40

• Acute on top of chronic:
Pao2<60mmHg
PaCo2 >50 mmHg

HCO3 >26 mEq/L
PH<7.35
M acidosis
Uncompensated
Partially compensated
Compensated
Uncompensated
*PH < 7.35
*PaCo2 normal
*HCO3 < 22 ml eq/L
Partially compensated
*PH< 7.35
*PaCo2 < 36 mmHg
*HCO3 < 22 ml eq/L
Compensated
PH 7.35-7.40
PaCo2 < 35 mmHg
HCO3 < 22 mleq/L
M alkalosis
Uncompensated
Partially compensated
Compensated
Uncompensated
PH > 7.45
PaCo2 normal
HCO3 >26 ml Eq/L
Partially compensated
PH >7.45
PaCo2 > 45 mmHg
HCO3 > 26 ml Eq/L
Compensated
PH 7.40-7.45
PaCo2 > 45 mmHg
HCO3 > 26 mlEq/L
Combined acidosis:
PH<7.35 PaCO2>50 HCO3<22

Combined alkalosis:
PH >7.45 PaCo2<35 HCO3>26
Blood Gas Analysis &
Acid-Base Disorders
Professor Gamal Rabie Agmy, MD, FCCP
Professor of Chest Diseases , Assiut
University
Blood Gas Analysis
Arterial blood
Sea level (101.3kPa, 760mmHg)
Quiet
Anti-coagulate blood
Inspire air (Whether O2 supply)
Why Order an ABG?
•
•
•
•

Aids in establishing a diagnosis
Helps guide treatment plan
Aids in ventilator management
Improvement in acid/base management
allows for optimal function of medications
• Acid/base status may alter electrolyte levels
critical to patient status/care
Clinical Significance
To evaluate oxygen status
To evaluate ventilation
To evaluate acid-base disorder
How to evaluate oxygen status?
PaO2:
Partial pressure of oxygen in Arterial
blood .
Normal: 95-98 mmHg (12.6-13 kPa)
Estimate formula of age:
PaO2=100mmHg-(age×0.33) ±5mmHg
Hypoxaemia
Mild: 80-60mmHg
Medorate: 60-40mmHg
Severe: <40mmHg
Respiratory Failure
PaO2<60mmHg  respiratory failure
Notice: sea level, quiet, inspire air
rule off other causes (Congenital
cyanotic heart disease and abnormal
types of Hg)
Classification of Respiratory Failure
PaCO2: The carbon dioxide partial
pressure
of arterial blood
Normal: 35-45mmHg (4.7-6.0kPa)
mean: 40mmHg
Classification of Respiratory Failure

PaO2 (mmHg)
PaCO2 (mmHg)

Type Ⅰ
<60
≤35-45

TypeⅡ
<60
>50
Other Parameters
SaO2: Saturation of arterial blood
oxygen
Normal: 0.95-0.98
Significance: a parameter to evaluate
hypoxaemia, but not sensitive

ODC ( Dissociation curve of
oxygenated hemoglobin): “S” shape
2

SaO %

PO2

Oxygen dissociation curve
PH

2,3DPG

temperature

CO2

ODC to right deviation

Oxygenated hemoglobin release oxygen
to tissue, prevent hypoxia of the tissue.
But absorbed oxygen of hemoglobin is
decreased from the alveoli.
Bohr effect: movement of ODC place is
induced by PH.
PA-aO2: Difference of alveoli-arterial
blood oxygenic partial pressure.
Normal: 15-20mmHg (<30mmHg in the
old)
Significance: a sensitive parameter in
gas exchange
PvO2: Partial pressure of oxygen in
mixed venous blood.
Normal: 35-45mmHg
mean: 40mmHg
Significance: Pa-vO2 is to reflect the
tissue absorbing oxygen.
CaO2: The content of the oxygen of the
arterial blood.
Normal: 19-21mmol/L
Significance: a comprehensive
parameter to evaluate arterial
oxygen.
Parameters in acid-basic disorder evaluation

PH: negative logarithm of
Hydrogen ion concentration.
Normal: 7.35-7.45
mean: 7.4
〔HCO3- 〕

PH=Pka+log
=6.1+log

0.03PaCO2

20

1
HCO3- (bicarbonate):
SB (standard bicarbonate)
AB (actual bicarbonate)
SB: the contents of HCO3- of serum of arterial
blood in 37℃, PaCO2 40mmHg, SaO2 100%.
Normal: 22-26 mmol/L
mean: 24mmol/L
AB: The contents of HCO3- in actual condition.
In normal person: AB=SB
AB and SB are parameters to reflect
metabolism, regulated by kidney.
Difference of AB-SB can reflect the
respiratory affection on serum HCO3- .
Respiratory acidosis: AB>SB
Respiratory alkalosis: AB<SB
Metabolic acidosis: AB=SB<Normal
Metabolic alkalosis: AB=SB>Normal
Buffer bases(BB):
is the total of buffer negative ion of
blood.
BB: HCO3hemoglobin
plasma proteins
HPO42- (phosphate)
Normal: 45-55mmol/L
mean: 50mmol/L
Significance: Metabolic acidosis:  BB
Metabolic alkalosis:  BB
Bases excess (BE):
the acid or bases used to regulate
blood PH 7.4 . ( in 38℃,PaCO2
40mmHg, SaO2 100%)
Normal: 0±2.3 mmol/L
Significance:
add acid: BE(+), BB
add base: BE(-), BB
Total plasma CO2 (T-CO2):
total content of the CO2 .
Normal: HCO3- >95%
Logistics
• When to order an arterial line -– Need for continuous BP monitoring
– Need for multiple ABGs
– COP measurement by thermodilution method

• Where to place -- the options
–
–
–
–
–

Radial
Femoral
Brachial
Dorsalis Pedis
Axillary
Acid Base Balance
• The body produces acids daily
– 15,000 mmol CO2
– 50-100 mEq Nonvolatile acids

• The lungs and kidneys attempt to
maintain balance
Acid Base Balance
• Assessment of status via bicarbonatecarbon dioxide buffer system
– CO2 + H2O <--> H2CO3 <--> HCO3- + H+
– ph = 6.10 + log ([HCO3] / [0.03 x PCO2])
The Terms
• ACIDS
– Acidemia
– Acidosis
• Respiratory
CO2
• Metabolic
HCO3

• BASES
– Alkalemia
– Alkalosis
• Respiratory
CO2
• Metabolic
HCO3
Respiratory Acidosis
• ph, CO2, Ventilation
• Causes
– CNS depression
– Pleural disease
– COPD/ARDS
– Musculoskeletal disorders
– Compensation for metabolic alkalosis
Respiratory Acidosis
• Acute vs Chronic
– Acute - little kidney involvement. Buffering
via titration via Hb for example
• pH by 0.08 for 10mmHg  in CO2

– Chronic - Renal compensation via
synthesis and retention of HCO3 (Cl to
balance charges  hypochloremia)
• pH by 0.03 for 10mmHg in CO2
Respiratory Alkalosis
• pH, CO2, Ventilation
•  CO2   HCO3 (Cl to balance charges 
hyperchloremia)
• Causes
–
–
–
–
–

Intracerebral hemorrhage
Salicylate and Progesterone drug usage
Anxiety  lung compliance
Cirrhosis of the liver
Sepsis
Respiratory Alkalosis
• Acute vs. Chronic
– Acute - HCO3 by 2 mEq/L for every
10mmHg  in PCO2
– Chronic - Ratio increases to 4 mEq/L of
HCO3 for every 10mmHg  in PCO2
– Decreased bicarb reabsorption and
decreased ammonium excretion to
normalize pH
Metabolic Acidosis
• pH, HCO3
• 12-24 hours for complete activation of
respiratory compensation
• PCO2 by 1.2mmHg for every 1 mEq/L
HCO3
• The degree of compensation is
assessed via the Winter’s Formula
 PCO2 = 1.5(HCO3) +8  2
The Causes
• Metabolic Gap
Acidosis
–
–
–
–
–
–
–
–

M - Methanol
U - Uremia
D - DKA
P - Paraldehyde
I - INH
L - Lactic Acidosis
E - Ehylene Glycol
S - Salicylate

• Non Gap Metabolic
Acidosis
– Hyperalimentation
– Acetazolamide
– RTA (Calculate urine
anion gap)
– Diarrhea
– Pancreatic Fistula
Metabolic Alkalosis
• pH, HCO3
• PCO2 by 0.7 for every 1mEq/L  in HCO3
• Causes
–
–
–
–
–

Vomiting
Diuretics
Chronic diarrhea
Hypokalemia
Renal Failure
Mixed Acid-Base Disorders
• Patients may have two or more acidbase disorders at one time
• Delta Gap
Delta HCO3 = HCO3 + Change in anion gap
Delta HCO3 >24 = metabolic alkalosis
The Steps
•
•
•
•

Start with the pH
Note the PCO2
Calculate anion gap
Determine compensation
Sample Problem #1
• An ill-appearing alcoholic male presents
with nausea and vomiting.
– ABG – 7.25 / 34 / 85 / 16
– Na- 137 / K- 3.8 / Cl- 90 / HCO3- 16
Sample Problem #1
• Anion Gap = 137 - (90 +16) =31
 anion gap metabolic acidosis
• Winters Formula = 1.5(16) + 8  2
= 32  2
 compensated
• Delta Gap =( 31 – 12) + 16 = 35
 metabolic alkalosis
Sample Problem #2
• 22 year old female presents for
attempted overdose. She has taken an
unknown amount of Midol containing
aspirin, cinnamedrine, and caffeine. On
exam she is experiencing respiratory
distress.
Sample Problem #2
• ABG - 7.47 / 19 / 123 / 14
• Na- 145 / K- 3.6 / Cl- 109 / HCO3- 14
• ASA level - 38.2 mg/dL
Sample Problem #2
• Anion Gap = 145 - (109 + 14) = 22
 anion gap metabolic acidosis
• Winters Formula = 1.5 (14) + 8  2
= 29  2
 uncompensated
• Delta Gap = 22 - 12 = 10
10 + 14 = 24
 no metabolic alkalosis
Sample Problem #3
• 47 year old male experienced crush
injury at construction site.
• ABG - 7.3 / 32 / 96 / 15
• Na- 135 / K-5 / Cl- 98 / HCO3- 15 /
BUN- 38 / Cr- 1.7
• CK- 42, 346
Sample Problem #3
• Anion Gap = 135 - (98 + 15) = 22
 anion gap metabolic acidosis
• Winters Formula = 1.5 (15) + 8  2
= 30  2
 compensated
• Delta Gap = 22 - 10 = 12
12 + 15 = 27
 mild metabolic alkalosis
Sample Problem #4
• 1 month old male presents with
projectile emesis x 2 days.
• ABG - 7.49 / 40 / 98 / 30
• Na- 140 / K- 2.9 / Cl- 92 / HCO3- 32
Sample Problem #4
• Metabolic Alkalosis, hypochloremic
• Winters Formula = 1.5 (30) + 8  2
= 53  2
 uncompensated
ABG Analysis, Introduction
• pH, PaCO2, PaO2 are measured directly
by special electrodes contained in a
device made for that purpose
• Other indirect measurements can be
made or calculated from the above
measurements i.e., HCO3-, O2 Sat.

SVCC Respiratory Care
Programs
QA in Blood Gas Analysis
• ABG lab must be able to assure
accurate and reliable results
• The above is accomplished by applying
protocols in 3 areas:
- pre-analytic error
- calibration
- quality control
SVCC Respiratory Care
Programs
Pre-analytic Error
• All factors that cause variance in lab results
prior to the sample arriving in the ABG lab.
• 4 factors assoc. with signif. P. E. are:
- air bubbles in sample
- time delay (iced sample with more than
60 min. or uniced with more
than
10 min.)
- blood clots in sample
- small sample size where excessive
anticaogulation is suspect
SVCC Respiratory Care
Programs
Calibration
• Purpose is assure consistency
• Def.: the systemic standardization of the
graduation of a quantitative measuring
instrument
• Calibrating standards for blood gas analyzers
should simulate the physical properties of
blood and meet manuf. specs.
• When 2 standards are used ---> 2-point
calibration, performed after 50 blood gases or
at least every 8 hours
SVCC Respiratory Care
Programs
Calibration (cont’d)
• A “one-point calibration” is an
adjustment of the electronic response of
an electrode to a single standard and is
performed more freq. than a 2 pt. cal.,
ideally prior to each sample analysis

SVCC Respiratory Care
Programs
Quality Control
• Refers to a system that documents the
accuracy and reliability of the blood gas
measurements and is essential to assure
accuracy in the blood gas lab
• Media available as blood gas controls
include:
- aqueous buffers
- glycerin soltn.
- human/animal serum and blood
- artificial blood
• A QC system must ID problems and specify
SVCC Respiratory Care
corrective action, document. of accept. oper.
Programs
QC (cont’d)
• Documentation of QC is usu. on LevyJennings Chart which shows measured
results on the y axis versus time of
measurement on the x axis
• SD is used to summarize a mass of data: the
difference between a number in a data set
and the mean of the data set is called a
deviation. A deviation shows how much a
number varies from the mean
SVCC Respiratory Care
Programs
QC (cont’d)
• A properly functioning electrode that
repeatedly analyzes a known value will
produce results within a rel. small range, e.g.,
a PaCO2 electrode that analyzes a 40 mmHg
standard 100 times will produce results where
2/3 of the measurements are 39 - 41 mmHg
and nearly all measurements fall in 38 - 42
range
• 95% of the control measurements should fall
within 2 SD
SVCC Respiratory Care
Programs
QC (cont’d)
• Random errors indicates a value outside of 2
SD of the mean: a single random error has
minor signif., but if number increased the
machine and techniques must be evaluated
• Systematic errors is recurrent measurable
deviation from the mean
• Causes of systematic errors:
- contaminated standard
- variations in electrode temp.

SVCC Respiratory Care
Programs
QC (cont’d)
• Causes of systematic error (cont’d)
- inconsistent calibration
technique
- change in QC
standard storage or prep. - electrode
problems, e.g., protein
contamin.,
membrane malfunction,
contamin. electrolyte, or electrical
problems
SVCC Respiratory Care
Programs
QC Levels
• Level 1 simulates a patient
hypoventilating
• Level 2 simulates a patient with normal
ventilatory status
• Level 3 simulates a patient
hyperventilating

SVCC Respiratory Care
Programs
HCO3- (bicarbonate):
SB (standard bicarbonate)
AB (actual bicarbonate)
SB: the contents of HCO3- of serum of arterial
blood in 37-38℃, PaCO2 40mmHg, SaO2 100%.
Normal: 22-27mmol/L
mean: 24mmol/L
AB: The contents of HCO3- in actual condition.
In normal person: AB=SB
AB and SB are parameters to reflect
metabolism, regulated by kidney.
Difference of AB-SB can reflect the
respiratory affection on serum HCO3- .
Respiratory acidosis: AB>SB
Respiratory alkalosis: AB<SB
Metabolic acidosis: AB=SB<Normal
Metabolic alkalosis: AB=SB>Normal
8 Sequential Rules:
• Rule #1
– Must know the pH; pH determines whether the
primary disorder is an acidosis or an alkalosis

• Rule #2
– Must know the PaCO2 and serum HCO3-

• Rule #3
– Must be able to establish that the available data
(pH, PaCO2, and HCO3-) are consistent
Are the data consistent?
• The Henderson Equation:

H   24 


PaCO
HCO

2


3
Convert

+]
[H

to pH:

• Subtract calculated [H+] from 80; this gives
the last two digits of a pH beginning with 7
– example: calculated [H+] of 24 converts to pH
of (80-24)~7.56
– example: calculated [H+] of 53 converts to pH
of (80-53)~7.27

• Refer to table 1 in handout for more precise
conversion, or if calculated [H+] exceeds 80
Relationship between

+]
[H

& pH
Relationship between
+

+]
[H
+

& pH

pH

[H ]

pH

[H ]

7.80
7.75
7.70
7.65
7.60
7.55
7.50
7.45
7.40
7.35

16
18
20
22
25
28
32
35
40
45

7.30
7.25
7.20
7.15
7.10
7.00
6.95
6.90
6.85
6.80

50
56
63
71
79
89
100
112
141
159
Simple Acid-Base Disorders:
T y p e o f D iso rd er
M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis

pH


P a C O 2 [H C O 3 ]

Simple Acid-Base Disorders:
T y p e o f D iso rd er
M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis

pH


P a C O 2 [H C O 3 ]



Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis




Simple Acid-Base Disorders:
T y p e o f D iso rd er
T y p e o f D iso rd er

pH
pH

P a C O 2 [H C O 3 ]
P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A cid o sis
M etab o lic A lk alo sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis
A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis









Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis





C h ro n ic R esp irato ry A cid o sis





A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis
Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis







C h ro n ic R esp irato ry A cid o sis







A cu te R esp irato ry A lk alo sis
C h ro n ic R esp irato ry A lk alo sis
Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis





C h ro n ic R esp irato ry A lk alo sis




Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis
M etab o lic A lk alo sis
A cu te R esp irato ry A cid o sis
C h ro n ic R esp irato ry A cid o sis
A cu te R esp irato ry A lk alo sis







C h ro n ic R esp irato ry A lk alo sis






Simple Acid-Base Disorders:
T y p e o f D iso rd er

pH

P a C O 2 [H C O 3 ]

M etab o lic A cid o sis







M etab o lic A lk alo sis







A cu te R esp irato ry A cid o sis







C h ro n ic R esp irato ry A cid o sis







A cu te R esp irato ry A lk alo sis







C h ro n ic R esp irato ry A lk alo sis






Simple Acid-Base Disorders:
• The compensatory variable always changes
in the SAME DIRECTION as the
primarily deranged variable
• Compensation is always more pronounced
in CHRONIC RESPIRATORY disorders
than in acute respiratory disorders
8 Sequential Rules:
• Rule #4:
– must know if compensation is appropriate
– compensation never overshoots
• Must have known “rules of thumb” to
interpret appropriateness of compensation
Rules of Compensation:
• Metabolic Acidosis
– PaCO2 should fall by 1 to 1.5 mm Hg x the fall
in plasma [HCO3]

• Metabolic Alkalosis
– PaCO2 should rise by .25 to 1 mm Hg x the rise
in plasma [HCO3]
Rules of Compensation:
• Acute Respiratory Acidosis
– Plasma [HCO3] should rise by ~1mmole/l for
each 10 mm Hg increment in PaCO2

• Chronic Respiratory Acidosis
– Plasma [HCO3] should rise by ~4mmoles/l for
each 10 mm Hg increment in PaCO2
Rules of Compensation:
• Acute Respiratory Alkalosis
– Plasma [HCO3] should fall by ~1-3 mmole/l for
each 10 mm Hg decrement in PaCO2, usually
not to less than 18 mmoles/l

• Chronic Respiratory Alkalosis
– Plasma [HCO3] should fall by ~2-5 mmole/l for
each 10 mm Hg decrement in PaCO2, usually
not to less than 14 mmoles/l
Case #1:
• A 24 years old with chronic renal failure
presents to ER with history of increasing
azotemia, weakness, and lethargy. Exam
reveals the patient to be modestly
hypertensive, and tachypneic. Labs reveal
BUN=100 mg, and Creatinine=8 mg.
Case #1:
• Steps 1&2: must know pH, PaCO2, HCO3
• pH=7.37, PaCO2=22, and HCO3=12
• Step 3: are the available data consistent?

H   24 


PaCO
HCO

2


3
Case #1:
• [H+]=44, equates to pH~7.36; data are thus
consistent
• What is the primary disorder?
• “_________Acidosis”
• Which variable (PaCO2, HCO3) is deranged
in a direction consistent with acidosis?
• Primary disorder is “Metabolic Acidosis”
Is compensation appropriate?
• HCO3 is decreased by 12 mmoles/l
• PaCO2 should decrease by 1 to 1.5 times the
fall in HCO3; expect PaCO2 to decrease by
12-18 mm Hg or be between 22-28 mm Hg
• Since PaCO2 is 22 mm Hg, compensation is
appropriate, and the data are consistent with
a simple metabolic acidosis with respiratory
compensation
8 Sequential Rules:
• Rule #5:
– If the data are consistent with a simple disorder,
it does not guarantee that a simple disorder
exists; need to examine the patient’s history

• Rule #6:
– When compensatory responses do not lie within
the accepted range, by definition a combined
disorder exists.
Case #2:
• A 16 year old male with sickle cell anemia,
hemochromatosis, & subsequent cirrhosis,
presents with a several day history of
emesis. At presentation to the pedes ER, he
is hypotensive, orthostatic, and confused.
• What acid-base disorders might be
anticipated based on the above information?
Case #3:
• 16 yo male with sickle cell anemia, hemochromatosis, & subsequent cirrhosis, and
several days of emesis. In the pedes ER, he
is hypotensive, orthostatic, and confused.
• Emesis-loss of H+ (HCl)-metabolic alkalosis
• Orthostatic hypotension-?lactic acidosis
• SCD-decreased O2 delivery-?lactic acidosis
• Cirrhosis-decreased lactate metabolism
Case #3:
•
•
•
•

What baseline information is available?
pH=7.55, PaCO2=66
„lytes: Na+=166, K+=3.0, Cl-=90, HCO3=56
Are the data internally consistent?

H   24 


PaCO
HCO

2


3
Case #3:
•
•
•
•
•

[H+]~28, equates to pH~7.55; consistent
What is the primary abnormality?
“_________ Alkalosis”
PaCO2ed, HCO3 ed, therefore…….
“Metabolic Alkalosis” presumed due to
emesis
• Is compensation appropriate?
Case #3:
• Metabolic Alkalosis
– PaCO2 should rise by .25 to 1 mm Hg x the rise
in plasma [HCO3]

• HCO3 ed by 32; PaCO2 should  by 8-32
• PaCO2 ed by 26, so compensation appears
appropriate
• What about multiple risk factors for lactic
acidosis?
Case #3:
•
•
•
•
•
•

Could there be a concealed lactic acidosis?
What is the anion gap?
Na+- (Cl- + HCO3), normally 12-14
Anion gap here is 166 - (90 + 56) = 20
ed anion gap implies metabolic acidosis
Combined metabolic alkalosis &
metabolic acidosis therefore present
8 Sequential Rules:
• Rule #7: Always calculate the anion gap
• Often it is the only sign of an occult
metabolic acidosis
– acidotic patients partially treated with HCO3
– acidotic patients with emesis

• May be the only sign of metabolic acidosis
“concealed” by concomitant acid-base
disorders
Causes of  Anion Gap Acidosis:
• Endogenous acidosis
– Uremia (uncleared organic acids)
– Ketoacidosis, Lactic acidosis (increased organic
acid production), Rhabdomyolosis

• Exogenous acidosis
– ingestions: salicylate, iron; paraldehyde use

• Other Ingestions:
– Methanol toxicity, Ethylene Glycol toxicity
Causes of normal Anion Gap Acidosis:
•
•
•
•
•

Diarrhea
Isotonic saline infusion
Renal tubular acidosis
Acetazolamide
Ureterocolic shunt
Anion Gap:
• Based on the concept of electroneutrality; the
assumption that the sum of all available cations=
the sum of all available anions. Restated as:
• Na+ + Unmeasured Cations (UC) = Cl- + HCO3 +
Unmeasure Anions (UA); conventionally restated:
• Na+-(Cl-+HCO3)=UA-UC=Anion Gap=12 to 14
Anion Gap:
• Na+-(Cl-+HCO3)=UA-UC
• Serum albumin contributes ~1/2 of the total anion
equivalency of the “UA” pool. Assuming normal
electrolytes, a 1gm/dl decline in serum albumin
decreases the anion gap factitiously by 3 mEq/L.
Therefore an anion gap of 12 mEq/L is corrected
to 17-18 mEq/L when the serum albumin is half of
normal; this is an important correction factor in
settings of chronic illness or malnourished patients
Case #3:
• A 3 year old is brought to the pedes ER at
~3am, stuporous and tachypneic. History is
remarkable for his parents having cleaned
out their medicine cabinet earlier that day.
An ABG and electrolytes have been
accidentally drawn by the nurse.
Case #4:
• Available data: pH=7.53, PaCO2=12;
Na+=140, K+=3.0, Cl-=106, HCO3=10
• Are the data internally consistent?

H   24 


PaCO
HCO

2

3
Case #4:
•
•
•
•

[H+]~29, so pH~7.51; data consistent
What is the primary disturbance?
“__________ Alkalosis”
Which variable (PaCO2, HCO3) is deranged
in a direction consistent with alkalosis?
• ed PaCO2, ed HCO3; so “Respiratory
Alkalosis”
Case #4:
• Is compensation appropriate?
• Acute respiratory alkalosis
– Plasma [HCO3] should fall by ~1-3 mmole/l for
each 10 mm Hg decrement in PaCO2, usually
not to less than 18 mmoles/l

• PaCO2 ed by ~30 mm Hg; HCO3 should
fall by 3-9 mmole/l; HCO3  is too great, so

superimposed metabolic acidosis
Case #4:
• What is the anion gap?
• 140 - (106 + 10) = 24; elevated anion gap
consistent with metabolic acidosis
• What is the differential diagnosis?
• Combined (true) respiratory alkalosis and
metabolic acidosis seen in sepsis, or

salicylate intoxication
Case #5:
• A 5 year old with Bartter‟s Syndrome is
brought to clinic, where she collapses. She
has recently been febrile, but history is
otherwise unremarkable. An ABG and
serum electrolytes are obtained: pH=6.9,
PaCO2=81; Na+=142, K+=2.8, Cl-=87,
HCO3=16
Case #5:
• Are the data consistent?

H   24 


PaCO
HCO

2

3

• [H+]=122, pH~6.9; data are consistent
Case #5:
• What is the primary disturbance?
• “_________ Acidosis”
• Which variable (PaCO2, HCO3) is deranged
in a direction consistent with acidosis?
• Both; pick most abnormal value-• “Respiratory Acidosis”
• Is compensation appropriate?
Case #5:
• Acute Respiratory Acidosis
– Plasma [HCO3] should rise by ~1mmole/l for
each 10 mm Hg increment in PaCO2

• Since HCO3 is inappropriately depressed,
compensation is not appropriate, and there
is a concomitant metabolic acidosis as well
• What is the anion gap?
• AG=39, confirms metabolic acidosis
Case #5:
• Combined Respiratory Acidosis and
Metabolic Acidosis; are there other
disorders present?
• What about the dx of Bartter‟s Syndrome?
• Bartter‟s Syndrome characterized by
hypokalemic metabolic alkalosis
• Does this patient have a concealed
metabolic alkalosis?
Case #5:
• Anion gap is 39, or 25-27 greater than
normal
• Typically, increases in anion gap correlate
with decreases in HCO3
• Assuming a 1:1 relationship, as anion gap
increases by 25, HCO3 should fall by 25
• Starting HCO3 must have been 16 + 25 = 41
Case #5:
• Therefore, starting HCO3 was ~41 mmol/l,
consistent with expected chronic metabolic
alkalosis. This metabolic alkalosis was
“concealed” by the supervening profound

metabolic and respiratory acidoses
associated with her arrest event.
• Final diagnosis: Metabolic alkalosis,
metabolic acidosis, & respiratory acidosis
8 Sequential Rules; Rule #8
• Rule #8: Mixed Acid-Base Disorders
• Coexistant metabolic acidosis and
metabolic alkalosis may occur. Always
check the change in the anion gap vs.
decrement in bicarbonate to rule out a
concealed metabolic disorder.
Case #6:
• A 3 year old toddler is brought to the ER at
3 am after being found unarousable on his
bedroom floor, with urinary incontinence.
EMS monitoring at the scene revealed sinus
bradycardia. One amp of D50W and 5 mg
of naloxone were given IV without
response. Vital signs are stable; respiratory
effort is regular, but tachypneic. He is
acyanotic.
Case #6:
• Initial lab studies (lytes, ABG & urine tox
screen) are sent. Initial dextrostick is >800.
• Initial available data are:
• Na+=154, K=5.6, Cl=106, HCO3=5,
BUN=6 creatinine=1.7, glucose=804,
PO4=12.3, Ca++=9.8, NH4=160, serum
osms=517
• pH=6.80, PaCO2=33, PaO2=298
Case #6:
•
•
•
•
•
•
•

What is the primary disturbance?
________ Acidosis
Metabolic Acidosis
Is compensation appropriate?
No; PaCO2 level is inappropriately high
Are other disorders present?
Respiratory acidosis (due to evolving coma)
Case #6:
• What is our differential thus far?
– Anion gap vs. non-anion gap metabolic acidosis
– DKA, lactic acidosis, renal failure, ingestion

• The urine tox screen comes back negative
– What does urine tox screen actually screen for?

• The patient‟s IV falls out. He then has a
seizure, is incontinent of urine, and fills the
specimen bag you placed on ER arrival.
Case #6:
• What is the calculated serum osmolality,
and does an osmolal gap exist?
• 2(Na) + BUN/2.8 + Glucose/18
– Calculated=355, Measured=517

• What is the most likely diagnosis?
• How can this be confirmed definitively?
– Review of urinalysis
– Serum ethylene glycol level
Case #6:
Methanol, ethylene glycol
ethyl alcohol, isopropyl alcohol

Anion gap metabolic acidosis

Osmolal gap
Gap-Gap
*AG excess/HCO3 deficit=
(Measured AG-12)/ (24-measured HCO3)
*Ratio <1 in presence of high AG acidosis
means coexistance of normal AG metabolic
acidosis
*Ratio >1 in presence of high AG acidosis
means coexistance of metabolic alkalosis
Interpretation of arterial  blood gases:Traditional versus Modern

Weitere ähnliche Inhalte

Was ist angesagt?

step by step approach to arterial blood gas analysis
step by step approach to arterial blood gas analysisstep by step approach to arterial blood gas analysis
step by step approach to arterial blood gas analysisikramdr01
 
Basics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas InterpretationBasics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas Interpretationgueste36950a
 
Hepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku JosephHepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku JosephDr.Tinku Joseph
 
Basic ABG Interpretation
Basic ABG InterpretationBasic ABG Interpretation
Basic ABG InterpretationFaz Halim
 
12.Respiratory Failure
12.Respiratory Failure12.Respiratory Failure
12.Respiratory Failureghalan
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?Sun Yai-Cheng
 
Interpreting Blood Gases, Practical and easy approach
Interpreting Blood Gases, Practical and easy approachInterpreting Blood Gases, Practical and easy approach
Interpreting Blood Gases, Practical and easy approachMuhammad Asim Rana
 
L 5.approach to dyspnea
L 5.approach to dyspneaL 5.approach to dyspnea
L 5.approach to dyspneabilal natiq
 
ARTERIAL BLOOD GAS ANALYSIS
ARTERIAL BLOOD GAS ANALYSISARTERIAL BLOOD GAS ANALYSIS
ARTERIAL BLOOD GAS ANALYSISGOPAL GHOSH
 
Ventilation strategies in ards rachmale
Ventilation strategies in ards   rachmaleVentilation strategies in ards   rachmale
Ventilation strategies in ards rachmaleDang Thanh Tuan
 

Was ist angesagt? (20)

Lights criteria pleural diseases
Lights criteria  pleural diseasesLights criteria  pleural diseases
Lights criteria pleural diseases
 
Chylothorax
ChylothoraxChylothorax
Chylothorax
 
A a gradient fin
A a gradient finA a gradient fin
A a gradient fin
 
step by step approach to arterial blood gas analysis
step by step approach to arterial blood gas analysisstep by step approach to arterial blood gas analysis
step by step approach to arterial blood gas analysis
 
Basics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas InterpretationBasics In Arterial Blood Gas Interpretation
Basics In Arterial Blood Gas Interpretation
 
Hepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku JosephHepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku Joseph
 
Abg
AbgAbg
Abg
 
Sravan abg ppt modified
Sravan abg ppt modifiedSravan abg ppt modified
Sravan abg ppt modified
 
Basic ABG Interpretation
Basic ABG InterpretationBasic ABG Interpretation
Basic ABG Interpretation
 
12.Respiratory Failure
12.Respiratory Failure12.Respiratory Failure
12.Respiratory Failure
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?
 
Approach to pleural effusion
Approach to pleural effusionApproach to pleural effusion
Approach to pleural effusion
 
A-a Gradient simplified
A-a Gradient simplifiedA-a Gradient simplified
A-a Gradient simplified
 
Interpreting Blood Gases, Practical and easy approach
Interpreting Blood Gases, Practical and easy approachInterpreting Blood Gases, Practical and easy approach
Interpreting Blood Gases, Practical and easy approach
 
L 5.approach to dyspnea
L 5.approach to dyspneaL 5.approach to dyspnea
L 5.approach to dyspnea
 
ARTERIAL BLOOD GAS ANALYSIS
ARTERIAL BLOOD GAS ANALYSISARTERIAL BLOOD GAS ANALYSIS
ARTERIAL BLOOD GAS ANALYSIS
 
Dypsnea
DypsneaDypsnea
Dypsnea
 
Ventilation strategies in ards rachmale
Ventilation strategies in ards   rachmaleVentilation strategies in ards   rachmale
Ventilation strategies in ards rachmale
 
Abg 2014
Abg 2014Abg 2014
Abg 2014
 

Andere mochten auch

Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBassel Ericsoussi, MD
 
Spectrum of pulmonary asperigellosis
Spectrum of pulmonary asperigellosisSpectrum of pulmonary asperigellosis
Spectrum of pulmonary asperigellosisGamal Agmy
 
Diffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung DiseasesDiffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung DiseasesAshraf ElAdawy
 
Thoracic imaging terms part 1
Thoracic imaging terms part 1Thoracic imaging terms part 1
Thoracic imaging terms part 1Gamal Agmy
 
Sonography in early diagnosis of chest diseases
Sonography in early diagnosis of chest diseasesSonography in early diagnosis of chest diseases
Sonography in early diagnosis of chest diseasesGamal Agmy
 
Chest radiology part 1
Chest radiology part 1Chest radiology part 1
Chest radiology part 1Gamal Agmy
 
Glossary of thoracic imaging terms part 1
Glossary of thoracic imaging terms part 1Glossary of thoracic imaging terms part 1
Glossary of thoracic imaging terms part 1Gamal Agmy
 
DIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEDIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEAshraf Hefny
 
Controversial Issues in NIV
Controversial Issues in NIVControversial Issues in NIV
Controversial Issues in NIVGamal Agmy
 
Interstitial Lung Disease
Interstitial Lung DiseaseInterstitial Lung Disease
Interstitial Lung Diseaseguest37d6e
 
Electromagnetic Navigation Bronchoscopy (ENB): Clinical Review
Electromagnetic Navigation Bronchoscopy (ENB): Clinical ReviewElectromagnetic Navigation Bronchoscopy (ENB): Clinical Review
Electromagnetic Navigation Bronchoscopy (ENB): Clinical ReviewBassel Ericsoussi, MD
 
Approach To Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung DiseasesApproach To Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung DiseasesGamal Agmy
 
Medastinal lymphadenopathy
Medastinal lymphadenopathyMedastinal lymphadenopathy
Medastinal lymphadenopathyGamal Agmy
 
Chest radiology part 2
Chest radiology part 2Chest radiology part 2
Chest radiology part 2Gamal Agmy
 
Approach To Diffuse Parenchymal Lung Diseases
Approach To  Diffuse Parenchymal Lung DiseasesApproach To  Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung DiseasesGamal Agmy
 
Tracheostomy:When to perform and How to manage?
Tracheostomy:When to perform and How to manage?Tracheostomy:When to perform and How to manage?
Tracheostomy:When to perform and How to manage?Gamal Agmy
 
Chest radiology part 3
Chest radiology part 3Chest radiology part 3
Chest radiology part 3Gamal Agmy
 
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...Gamal Agmy
 

Andere mochten auch (20)

Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe AsthmaBronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
Bronchial Thermoplasty (BT) Novel Treatment for Patients with Severe Asthma
 
Spectrum of pulmonary asperigellosis
Spectrum of pulmonary asperigellosisSpectrum of pulmonary asperigellosis
Spectrum of pulmonary asperigellosis
 
Diffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung DiseasesDiffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung Diseases
 
Thoracic imaging terms part 1
Thoracic imaging terms part 1Thoracic imaging terms part 1
Thoracic imaging terms part 1
 
Sonography in early diagnosis of chest diseases
Sonography in early diagnosis of chest diseasesSonography in early diagnosis of chest diseases
Sonography in early diagnosis of chest diseases
 
Chest radiology part 1
Chest radiology part 1Chest radiology part 1
Chest radiology part 1
 
Glossary of thoracic imaging terms part 1
Glossary of thoracic imaging terms part 1Glossary of thoracic imaging terms part 1
Glossary of thoracic imaging terms part 1
 
DIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGEDIFFUSE ALVEOLAR HAEMORRHAGE
DIFFUSE ALVEOLAR HAEMORRHAGE
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Controversial Issues in NIV
Controversial Issues in NIVControversial Issues in NIV
Controversial Issues in NIV
 
Interstitial Lung Diseases
Interstitial Lung DiseasesInterstitial Lung Diseases
Interstitial Lung Diseases
 
Interstitial Lung Disease
Interstitial Lung DiseaseInterstitial Lung Disease
Interstitial Lung Disease
 
Electromagnetic Navigation Bronchoscopy (ENB): Clinical Review
Electromagnetic Navigation Bronchoscopy (ENB): Clinical ReviewElectromagnetic Navigation Bronchoscopy (ENB): Clinical Review
Electromagnetic Navigation Bronchoscopy (ENB): Clinical Review
 
Approach To Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung DiseasesApproach To Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung Diseases
 
Medastinal lymphadenopathy
Medastinal lymphadenopathyMedastinal lymphadenopathy
Medastinal lymphadenopathy
 
Chest radiology part 2
Chest radiology part 2Chest radiology part 2
Chest radiology part 2
 
Approach To Diffuse Parenchymal Lung Diseases
Approach To  Diffuse Parenchymal Lung DiseasesApproach To  Diffuse Parenchymal Lung Diseases
Approach To Diffuse Parenchymal Lung Diseases
 
Tracheostomy:When to perform and How to manage?
Tracheostomy:When to perform and How to manage?Tracheostomy:When to perform and How to manage?
Tracheostomy:When to perform and How to manage?
 
Chest radiology part 3
Chest radiology part 3Chest radiology part 3
Chest radiology part 3
 
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...
Unilateral pleural effusion in liver cirrhosis, congestive heart failure and ...
 

Ähnlich wie Interpretation of arterial blood gases:Traditional versus Modern

Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Mohit Aggarwal
 
balance acido base.pptx
balance acido base.pptxbalance acido base.pptx
balance acido base.pptxjavier
 
acido base jeringa.pptx
acido base jeringa.pptxacido base jeringa.pptx
acido base jeringa.pptxjavier
 
abg-151118185050-lva1-app68911111111.pdf
abg-151118185050-lva1-app68911111111.pdfabg-151118185050-lva1-app68911111111.pdf
abg-151118185050-lva1-app68911111111.pdfDivyanshJoshi39
 
Arterial blood gas analysis
Arterial blood gas analysisArterial blood gas analysis
Arterial blood gas analysisKrishna Yadarala
 
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptx
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptxSTEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptx
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptxekramy abdo
 
Introduction to arterial blood gases
Introduction to arterial blood gasesIntroduction to arterial blood gases
Introduction to arterial blood gasesGeorge Abraham
 
Acid base and ABG interpretation in ICU
Acid base and ABG interpretation in  ICUAcid base and ABG interpretation in  ICU
Acid base and ABG interpretation in ICUAnwar Yusr
 
Abg analysis in emergency medicine department
Abg analysis in emergency medicine departmentAbg analysis in emergency medicine department
Abg analysis in emergency medicine departmentDrRahulyadav7
 
ARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATIONARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATIONDr.RMLIMS lucknow
 
ABG interpret in critical care 16-1-2024
ABG interpret in critical care 16-1-2024ABG interpret in critical care 16-1-2024
ABG interpret in critical care 16-1-2024Anwar Yusr
 
abg content.pptx
abg content.pptxabg content.pptx
abg content.pptxjavier
 
6.arterial blood gas analysis (2).ppt
6.arterial             blood gas analysis (2).ppt6.arterial             blood gas analysis (2).ppt
6.arterial blood gas analysis (2).pptAnthonyMatu1
 
PHYSIO_ ABG Analysis
PHYSIO_ ABG AnalysisPHYSIO_ ABG Analysis
PHYSIO_ ABG Analysiswaytoway91
 
ABG intreptretation on clinical setup-1.pptx
ABG intreptretation on clinical setup-1.pptxABG intreptretation on clinical setup-1.pptx
ABG intreptretation on clinical setup-1.pptxpugalrockzz1
 
ABG intreptretation.pptx important topic
ABG intreptretation.pptx important topicABG intreptretation.pptx important topic
ABG intreptretation.pptx important topicRajender Singh Lodhi
 

Ähnlich wie Interpretation of arterial blood gases:Traditional versus Modern (20)

Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)Arterial blood gas analysis in clinical practice (2)
Arterial blood gas analysis in clinical practice (2)
 
balance acido base.pptx
balance acido base.pptxbalance acido base.pptx
balance acido base.pptx
 
DNB OSCE ON ABG
DNB OSCE ON ABGDNB OSCE ON ABG
DNB OSCE ON ABG
 
acido base jeringa.pptx
acido base jeringa.pptxacido base jeringa.pptx
acido base jeringa.pptx
 
abg-151118185050-lva1-app68911111111.pdf
abg-151118185050-lva1-app68911111111.pdfabg-151118185050-lva1-app68911111111.pdf
abg-151118185050-lva1-app68911111111.pdf
 
Arterial blood gas analysis
Arterial blood gas analysisArterial blood gas analysis
Arterial blood gas analysis
 
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptx
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptxSTEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptx
STEP_BY_STEP_ABG_INTERPRETATION_SULEKHA_FINAL.pptx
 
ABG by a taecher
ABG by a taecherABG by a taecher
ABG by a taecher
 
Introduction to arterial blood gases
Introduction to arterial blood gasesIntroduction to arterial blood gases
Introduction to arterial blood gases
 
Acid base and ABG interpretation in ICU
Acid base and ABG interpretation in  ICUAcid base and ABG interpretation in  ICU
Acid base and ABG interpretation in ICU
 
Abg analysis in emergency medicine department
Abg analysis in emergency medicine departmentAbg analysis in emergency medicine department
Abg analysis in emergency medicine department
 
ARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATIONARTERIAL BLOOD GASES INTERPRETATION
ARTERIAL BLOOD GASES INTERPRETATION
 
ABG interpret in critical care 16-1-2024
ABG interpret in critical care 16-1-2024ABG interpret in critical care 16-1-2024
ABG interpret in critical care 16-1-2024
 
abg content.pptx
abg content.pptxabg content.pptx
abg content.pptx
 
6.arterial blood gas analysis (2).ppt
6.arterial             blood gas analysis (2).ppt6.arterial             blood gas analysis (2).ppt
6.arterial blood gas analysis (2).ppt
 
PHYSIO_ ABG Analysis
PHYSIO_ ABG AnalysisPHYSIO_ ABG Analysis
PHYSIO_ ABG Analysis
 
ABG intreptretation on clinical setup-1.pptx
ABG intreptretation on clinical setup-1.pptxABG intreptretation on clinical setup-1.pptx
ABG intreptretation on clinical setup-1.pptx
 
ABG intreptretation.pptx important topic
ABG intreptretation.pptx important topicABG intreptretation.pptx important topic
ABG intreptretation.pptx important topic
 
ABG Analysis & Interpretation
ABG Analysis & InterpretationABG Analysis & Interpretation
ABG Analysis & Interpretation
 
Abg may 2021
Abg may 2021Abg may 2021
Abg may 2021
 

Mehr von Gamal Agmy

Snap Shots in ILDs.ppt
Snap Shots in ILDs.pptSnap Shots in ILDs.ppt
Snap Shots in ILDs.pptGamal Agmy
 
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)Gamal Agmy
 
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)Gamal Agmy
 
Radiological Presentation of COVID 19
Radiological Presentation of COVID 19Radiological Presentation of COVID 19
Radiological Presentation of COVID 19Gamal Agmy
 
Antibiotic Strategy in Lower Respiratory Tract Infections
Antibiotic Strategy in Lower Respiratory Tract InfectionsAntibiotic Strategy in Lower Respiratory Tract Infections
Antibiotic Strategy in Lower Respiratory Tract InfectionsGamal Agmy
 
Imaging of Pulmonary Vascular Lesions ``
Imaging of Pulmonary Vascular Lesions ``Imaging of Pulmonary Vascular Lesions ``
Imaging of Pulmonary Vascular Lesions ``Gamal Agmy
 
Pneumomediastinum
PneumomediastinumPneumomediastinum
PneumomediastinumGamal Agmy
 
Management Dilemmas in Acute Pulmonary Embolism
Management Dilemmas in Acute Pulmonary Embolism Management Dilemmas in Acute Pulmonary Embolism
Management Dilemmas in Acute Pulmonary Embolism Gamal Agmy
 
Imaging of Mediastinum
Imaging of MediastinumImaging of Mediastinum
Imaging of MediastinumGamal Agmy
 
Imaging of pulmonary vascular lesions
Imaging of pulmonary vascular lesionsImaging of pulmonary vascular lesions
Imaging of pulmonary vascular lesionsGamal Agmy
 
Transthoacic Sonography
Transthoacic SonographyTransthoacic Sonography
Transthoacic SonographyGamal Agmy
 
:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent UpdatesGamal Agmy
 
Radiological Presentation of Pulmonary Pathology
Radiological Presentation of Pulmonary PathologyRadiological Presentation of Pulmonary Pathology
Radiological Presentation of Pulmonary PathologyGamal Agmy
 
Oxygen Therapy is not Beneficial in COPD Patients with Moderate Hypoxaemia
Oxygen Therapy is not  Beneficial in COPD Patients with Moderate HypoxaemiaOxygen Therapy is not  Beneficial in COPD Patients with Moderate Hypoxaemia
Oxygen Therapy is not Beneficial in COPD Patients with Moderate HypoxaemiaGamal Agmy
 
Using Imaging as a Biomarker for Asthma
Using Imaging as a Biomarker for AsthmaUsing Imaging as a Biomarker for Asthma
Using Imaging as a Biomarker for AsthmaGamal Agmy
 
Discontinuing Mechanical Ventilation in ICU
Discontinuing Mechanical Ventilation in ICUDiscontinuing Mechanical Ventilation in ICU
Discontinuing Mechanical Ventilation in ICUGamal Agmy
 
Ultrasound in ICU and Emergency
Ultrasound in ICU and EmergencyUltrasound in ICU and Emergency
Ultrasound in ICU and EmergencyGamal Agmy
 
Arterial Blood Gases Analysis
Arterial Blood Gases AnalysisArterial Blood Gases Analysis
Arterial Blood Gases AnalysisGamal Agmy
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPDGamal Agmy
 

Mehr von Gamal Agmy (20)

Snap Shots in ILDs.ppt
Snap Shots in ILDs.pptSnap Shots in ILDs.ppt
Snap Shots in ILDs.ppt
 
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 1)
 
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
Antibiotic Strategy in Lower Respiratory Tract Infections (part 2)
 
Radiological Presentation of COVID 19
Radiological Presentation of COVID 19Radiological Presentation of COVID 19
Radiological Presentation of COVID 19
 
COVID 19
COVID 19  COVID 19
COVID 19
 
Antibiotic Strategy in Lower Respiratory Tract Infections
Antibiotic Strategy in Lower Respiratory Tract InfectionsAntibiotic Strategy in Lower Respiratory Tract Infections
Antibiotic Strategy in Lower Respiratory Tract Infections
 
Imaging of Pulmonary Vascular Lesions ``
Imaging of Pulmonary Vascular Lesions ``Imaging of Pulmonary Vascular Lesions ``
Imaging of Pulmonary Vascular Lesions ``
 
Pneumomediastinum
PneumomediastinumPneumomediastinum
Pneumomediastinum
 
Management Dilemmas in Acute Pulmonary Embolism
Management Dilemmas in Acute Pulmonary Embolism Management Dilemmas in Acute Pulmonary Embolism
Management Dilemmas in Acute Pulmonary Embolism
 
Imaging of Mediastinum
Imaging of MediastinumImaging of Mediastinum
Imaging of Mediastinum
 
Imaging of pulmonary vascular lesions
Imaging of pulmonary vascular lesionsImaging of pulmonary vascular lesions
Imaging of pulmonary vascular lesions
 
Transthoacic Sonography
Transthoacic SonographyTransthoacic Sonography
Transthoacic Sonography
 
:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates:Weaning from Mechanical Ventilation :Recent Updates
:Weaning from Mechanical Ventilation :Recent Updates
 
Radiological Presentation of Pulmonary Pathology
Radiological Presentation of Pulmonary PathologyRadiological Presentation of Pulmonary Pathology
Radiological Presentation of Pulmonary Pathology
 
Oxygen Therapy is not Beneficial in COPD Patients with Moderate Hypoxaemia
Oxygen Therapy is not  Beneficial in COPD Patients with Moderate HypoxaemiaOxygen Therapy is not  Beneficial in COPD Patients with Moderate Hypoxaemia
Oxygen Therapy is not Beneficial in COPD Patients with Moderate Hypoxaemia
 
Using Imaging as a Biomarker for Asthma
Using Imaging as a Biomarker for AsthmaUsing Imaging as a Biomarker for Asthma
Using Imaging as a Biomarker for Asthma
 
Discontinuing Mechanical Ventilation in ICU
Discontinuing Mechanical Ventilation in ICUDiscontinuing Mechanical Ventilation in ICU
Discontinuing Mechanical Ventilation in ICU
 
Ultrasound in ICU and Emergency
Ultrasound in ICU and EmergencyUltrasound in ICU and Emergency
Ultrasound in ICU and Emergency
 
Arterial Blood Gases Analysis
Arterial Blood Gases AnalysisArterial Blood Gases Analysis
Arterial Blood Gases Analysis
 
Updates in Diagnosis of COPD
Updates in Diagnosis of COPDUpdates in Diagnosis of COPD
Updates in Diagnosis of COPD
 

Kürzlich hochgeladen

Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 

Kürzlich hochgeladen (20)

Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 

Interpretation of arterial blood gases:Traditional versus Modern

  • 1.
  • 2. Interpretation of Arterial Blood Gases Traditional Vs Modern By Gamal Rabie Agmy , MD , FCCP Professor of Chest Diseases ,Assiut University
  • 3. Handerson Hasselbach Equation • • • • • • PH= pKa+ Log HCO3/PaCo2 PH= Log HCO3/PaCo2 PH=  HCO3 PH=  HCO3  PH=  PaCo2 PH=  PaCo2
  • 5.
  • 6. Normal Values • PH 7.35-7.45 • HCO3 22-26 mEq/L • PaCo2 35-45 mmHg • PaO2 97 mmHg • BE/BD +2 to -2 • Haemoglobin 15 gram • A-a O2 gradient N < 15 A-a O2 gradient OLDER PERSONS – 2.5 +0.25*AGE – eg. AGE 60, 2.5+15=17.5 – eg. AGE 80, 2.5+20=22.5
  • 7.
  • 8. Definition of Respiratory Failure Respiratory failure is a syndrome of inadequate gas exchange due to dysfunction of one or more essential components of the respiratory system
  • 9. Types of Respiratory Failure Type 1 (Hypoxemic ): * PO2 < 60 mmHg on room air. Type 2 (Hypercapnic / Ventilatory): *PCO2 > 50 mmHg Type 3 (Peri-operative): *This is generally a subset of type 1 failure but is sometimes considered separately because it is so common. Type 4 (Shock): * secondary to cardiovascular instability.
  • 11. Brainstem Airway Lung Spinal cord Nerve root Nerve Pleura Chest wall Neuromuscular junction Respiratory muscle Sites at which disease may cause ventilatory disturbance
  • 12. Types of RF: • Type 1: A-Acute B-Chronic C-Acute on top of chronic • Type 2: A-Acute B-Chronic C-Acute on top of chronic
  • 13. Types of RF: • Type 1: PaO2<60 mm Hg PaCo235-45 mmHg • Type 2: PaO2<60 mm Hg PaCo2>50 mmHg
  • 14. Types of RF: Type 1: • Acute: Pao2<60mmHg PaCo235-45mmHg HCO3 Normal PH > 7.45 • Chronic: Pao2<60mmHg HCO3 <22mEq/L PaCo235-45mmHg PH=7.40-7.45 • Acute on top of chronic: Pao2<60mmHg PaCo235-45mmHg HCO3 <22mEq/L PH > 7.45
  • 15. Types of RF: Type 2: • Acute: Pao2<60mmHg PaCo2>50 mmHg HCO3 Normal PH<7.35 • Chronic: Pao2<60mmHg HCO3 >26 mEq/L PaCo2 >50 mmHg PH=7.35-7.40 • Acute on top of chronic: Pao2<60mmHg PaCo2 >50 mmHg HCO3 >26 mEq/L PH<7.35
  • 16.
  • 18. Uncompensated *PH < 7.35 *PaCo2 normal *HCO3 < 22 ml eq/L
  • 19. Partially compensated *PH< 7.35 *PaCo2 < 36 mmHg *HCO3 < 22 ml eq/L
  • 20. Compensated PH 7.35-7.40 PaCo2 < 35 mmHg HCO3 < 22 mleq/L
  • 22. Uncompensated PH > 7.45 PaCo2 normal HCO3 >26 ml Eq/L
  • 23. Partially compensated PH >7.45 PaCo2 > 45 mmHg HCO3 > 26 ml Eq/L
  • 24. Compensated PH 7.40-7.45 PaCo2 > 45 mmHg HCO3 > 26 mlEq/L
  • 25.
  • 26. Combined acidosis: PH<7.35 PaCO2>50 HCO3<22 Combined alkalosis: PH >7.45 PaCo2<35 HCO3>26
  • 27. Blood Gas Analysis & Acid-Base Disorders Professor Gamal Rabie Agmy, MD, FCCP Professor of Chest Diseases , Assiut University
  • 28. Blood Gas Analysis Arterial blood Sea level (101.3kPa, 760mmHg) Quiet Anti-coagulate blood Inspire air (Whether O2 supply)
  • 29. Why Order an ABG? • • • • Aids in establishing a diagnosis Helps guide treatment plan Aids in ventilator management Improvement in acid/base management allows for optimal function of medications • Acid/base status may alter electrolyte levels critical to patient status/care
  • 30. Clinical Significance To evaluate oxygen status To evaluate ventilation To evaluate acid-base disorder
  • 31. How to evaluate oxygen status? PaO2: Partial pressure of oxygen in Arterial blood . Normal: 95-98 mmHg (12.6-13 kPa) Estimate formula of age: PaO2=100mmHg-(age×0.33) ±5mmHg
  • 33. Respiratory Failure PaO2<60mmHg  respiratory failure Notice: sea level, quiet, inspire air rule off other causes (Congenital cyanotic heart disease and abnormal types of Hg)
  • 34. Classification of Respiratory Failure PaCO2: The carbon dioxide partial pressure of arterial blood Normal: 35-45mmHg (4.7-6.0kPa) mean: 40mmHg
  • 35. Classification of Respiratory Failure PaO2 (mmHg) PaCO2 (mmHg) Type Ⅰ <60 ≤35-45 TypeⅡ <60 >50
  • 36. Other Parameters SaO2: Saturation of arterial blood oxygen Normal: 0.95-0.98 Significance: a parameter to evaluate hypoxaemia, but not sensitive ODC ( Dissociation curve of oxygenated hemoglobin): “S” shape
  • 38. PH 2,3DPG temperature CO2 ODC to right deviation Oxygenated hemoglobin release oxygen to tissue, prevent hypoxia of the tissue. But absorbed oxygen of hemoglobin is decreased from the alveoli. Bohr effect: movement of ODC place is induced by PH.
  • 39. PA-aO2: Difference of alveoli-arterial blood oxygenic partial pressure. Normal: 15-20mmHg (<30mmHg in the old) Significance: a sensitive parameter in gas exchange
  • 40. PvO2: Partial pressure of oxygen in mixed venous blood. Normal: 35-45mmHg mean: 40mmHg Significance: Pa-vO2 is to reflect the tissue absorbing oxygen.
  • 41. CaO2: The content of the oxygen of the arterial blood. Normal: 19-21mmol/L Significance: a comprehensive parameter to evaluate arterial oxygen.
  • 42. Parameters in acid-basic disorder evaluation PH: negative logarithm of Hydrogen ion concentration. Normal: 7.35-7.45 mean: 7.4 〔HCO3- 〕 PH=Pka+log =6.1+log 0.03PaCO2 20 1
  • 43. HCO3- (bicarbonate): SB (standard bicarbonate) AB (actual bicarbonate) SB: the contents of HCO3- of serum of arterial blood in 37℃, PaCO2 40mmHg, SaO2 100%. Normal: 22-26 mmol/L mean: 24mmol/L AB: The contents of HCO3- in actual condition. In normal person: AB=SB
  • 44. AB and SB are parameters to reflect metabolism, regulated by kidney. Difference of AB-SB can reflect the respiratory affection on serum HCO3- . Respiratory acidosis: AB>SB Respiratory alkalosis: AB<SB Metabolic acidosis: AB=SB<Normal Metabolic alkalosis: AB=SB>Normal
  • 45. Buffer bases(BB): is the total of buffer negative ion of blood. BB: HCO3hemoglobin plasma proteins HPO42- (phosphate) Normal: 45-55mmol/L mean: 50mmol/L Significance: Metabolic acidosis:  BB Metabolic alkalosis:  BB
  • 46. Bases excess (BE): the acid or bases used to regulate blood PH 7.4 . ( in 38℃,PaCO2 40mmHg, SaO2 100%) Normal: 0±2.3 mmol/L Significance: add acid: BE(+), BB add base: BE(-), BB
  • 47. Total plasma CO2 (T-CO2): total content of the CO2 . Normal: HCO3- >95%
  • 48. Logistics • When to order an arterial line -– Need for continuous BP monitoring – Need for multiple ABGs – COP measurement by thermodilution method • Where to place -- the options – – – – – Radial Femoral Brachial Dorsalis Pedis Axillary
  • 49. Acid Base Balance • The body produces acids daily – 15,000 mmol CO2 – 50-100 mEq Nonvolatile acids • The lungs and kidneys attempt to maintain balance
  • 50. Acid Base Balance • Assessment of status via bicarbonatecarbon dioxide buffer system – CO2 + H2O <--> H2CO3 <--> HCO3- + H+ – ph = 6.10 + log ([HCO3] / [0.03 x PCO2])
  • 51. The Terms • ACIDS – Acidemia – Acidosis • Respiratory CO2 • Metabolic HCO3 • BASES – Alkalemia – Alkalosis • Respiratory CO2 • Metabolic HCO3
  • 52. Respiratory Acidosis • ph, CO2, Ventilation • Causes – CNS depression – Pleural disease – COPD/ARDS – Musculoskeletal disorders – Compensation for metabolic alkalosis
  • 53. Respiratory Acidosis • Acute vs Chronic – Acute - little kidney involvement. Buffering via titration via Hb for example • pH by 0.08 for 10mmHg  in CO2 – Chronic - Renal compensation via synthesis and retention of HCO3 (Cl to balance charges  hypochloremia) • pH by 0.03 for 10mmHg in CO2
  • 54. Respiratory Alkalosis • pH, CO2, Ventilation •  CO2   HCO3 (Cl to balance charges  hyperchloremia) • Causes – – – – – Intracerebral hemorrhage Salicylate and Progesterone drug usage Anxiety  lung compliance Cirrhosis of the liver Sepsis
  • 55. Respiratory Alkalosis • Acute vs. Chronic – Acute - HCO3 by 2 mEq/L for every 10mmHg  in PCO2 – Chronic - Ratio increases to 4 mEq/L of HCO3 for every 10mmHg  in PCO2 – Decreased bicarb reabsorption and decreased ammonium excretion to normalize pH
  • 56. Metabolic Acidosis • pH, HCO3 • 12-24 hours for complete activation of respiratory compensation • PCO2 by 1.2mmHg for every 1 mEq/L HCO3 • The degree of compensation is assessed via the Winter’s Formula  PCO2 = 1.5(HCO3) +8  2
  • 57. The Causes • Metabolic Gap Acidosis – – – – – – – – M - Methanol U - Uremia D - DKA P - Paraldehyde I - INH L - Lactic Acidosis E - Ehylene Glycol S - Salicylate • Non Gap Metabolic Acidosis – Hyperalimentation – Acetazolamide – RTA (Calculate urine anion gap) – Diarrhea – Pancreatic Fistula
  • 58. Metabolic Alkalosis • pH, HCO3 • PCO2 by 0.7 for every 1mEq/L  in HCO3 • Causes – – – – – Vomiting Diuretics Chronic diarrhea Hypokalemia Renal Failure
  • 59. Mixed Acid-Base Disorders • Patients may have two or more acidbase disorders at one time • Delta Gap Delta HCO3 = HCO3 + Change in anion gap Delta HCO3 >24 = metabolic alkalosis
  • 60. The Steps • • • • Start with the pH Note the PCO2 Calculate anion gap Determine compensation
  • 61. Sample Problem #1 • An ill-appearing alcoholic male presents with nausea and vomiting. – ABG – 7.25 / 34 / 85 / 16 – Na- 137 / K- 3.8 / Cl- 90 / HCO3- 16
  • 62. Sample Problem #1 • Anion Gap = 137 - (90 +16) =31  anion gap metabolic acidosis • Winters Formula = 1.5(16) + 8  2 = 32  2  compensated • Delta Gap =( 31 – 12) + 16 = 35  metabolic alkalosis
  • 63. Sample Problem #2 • 22 year old female presents for attempted overdose. She has taken an unknown amount of Midol containing aspirin, cinnamedrine, and caffeine. On exam she is experiencing respiratory distress.
  • 64. Sample Problem #2 • ABG - 7.47 / 19 / 123 / 14 • Na- 145 / K- 3.6 / Cl- 109 / HCO3- 14 • ASA level - 38.2 mg/dL
  • 65. Sample Problem #2 • Anion Gap = 145 - (109 + 14) = 22  anion gap metabolic acidosis • Winters Formula = 1.5 (14) + 8  2 = 29  2  uncompensated • Delta Gap = 22 - 12 = 10 10 + 14 = 24  no metabolic alkalosis
  • 66. Sample Problem #3 • 47 year old male experienced crush injury at construction site. • ABG - 7.3 / 32 / 96 / 15 • Na- 135 / K-5 / Cl- 98 / HCO3- 15 / BUN- 38 / Cr- 1.7 • CK- 42, 346
  • 67. Sample Problem #3 • Anion Gap = 135 - (98 + 15) = 22  anion gap metabolic acidosis • Winters Formula = 1.5 (15) + 8  2 = 30  2  compensated • Delta Gap = 22 - 10 = 12 12 + 15 = 27  mild metabolic alkalosis
  • 68. Sample Problem #4 • 1 month old male presents with projectile emesis x 2 days. • ABG - 7.49 / 40 / 98 / 30 • Na- 140 / K- 2.9 / Cl- 92 / HCO3- 32
  • 69. Sample Problem #4 • Metabolic Alkalosis, hypochloremic • Winters Formula = 1.5 (30) + 8  2 = 53  2  uncompensated
  • 70. ABG Analysis, Introduction • pH, PaCO2, PaO2 are measured directly by special electrodes contained in a device made for that purpose • Other indirect measurements can be made or calculated from the above measurements i.e., HCO3-, O2 Sat. SVCC Respiratory Care Programs
  • 71. QA in Blood Gas Analysis • ABG lab must be able to assure accurate and reliable results • The above is accomplished by applying protocols in 3 areas: - pre-analytic error - calibration - quality control SVCC Respiratory Care Programs
  • 72. Pre-analytic Error • All factors that cause variance in lab results prior to the sample arriving in the ABG lab. • 4 factors assoc. with signif. P. E. are: - air bubbles in sample - time delay (iced sample with more than 60 min. or uniced with more than 10 min.) - blood clots in sample - small sample size where excessive anticaogulation is suspect SVCC Respiratory Care Programs
  • 73. Calibration • Purpose is assure consistency • Def.: the systemic standardization of the graduation of a quantitative measuring instrument • Calibrating standards for blood gas analyzers should simulate the physical properties of blood and meet manuf. specs. • When 2 standards are used ---> 2-point calibration, performed after 50 blood gases or at least every 8 hours SVCC Respiratory Care Programs
  • 74. Calibration (cont’d) • A “one-point calibration” is an adjustment of the electronic response of an electrode to a single standard and is performed more freq. than a 2 pt. cal., ideally prior to each sample analysis SVCC Respiratory Care Programs
  • 75. Quality Control • Refers to a system that documents the accuracy and reliability of the blood gas measurements and is essential to assure accuracy in the blood gas lab • Media available as blood gas controls include: - aqueous buffers - glycerin soltn. - human/animal serum and blood - artificial blood • A QC system must ID problems and specify SVCC Respiratory Care corrective action, document. of accept. oper. Programs
  • 76. QC (cont’d) • Documentation of QC is usu. on LevyJennings Chart which shows measured results on the y axis versus time of measurement on the x axis • SD is used to summarize a mass of data: the difference between a number in a data set and the mean of the data set is called a deviation. A deviation shows how much a number varies from the mean SVCC Respiratory Care Programs
  • 77. QC (cont’d) • A properly functioning electrode that repeatedly analyzes a known value will produce results within a rel. small range, e.g., a PaCO2 electrode that analyzes a 40 mmHg standard 100 times will produce results where 2/3 of the measurements are 39 - 41 mmHg and nearly all measurements fall in 38 - 42 range • 95% of the control measurements should fall within 2 SD SVCC Respiratory Care Programs
  • 78. QC (cont’d) • Random errors indicates a value outside of 2 SD of the mean: a single random error has minor signif., but if number increased the machine and techniques must be evaluated • Systematic errors is recurrent measurable deviation from the mean • Causes of systematic errors: - contaminated standard - variations in electrode temp. SVCC Respiratory Care Programs
  • 79. QC (cont’d) • Causes of systematic error (cont’d) - inconsistent calibration technique - change in QC standard storage or prep. - electrode problems, e.g., protein contamin., membrane malfunction, contamin. electrolyte, or electrical problems SVCC Respiratory Care Programs
  • 80. QC Levels • Level 1 simulates a patient hypoventilating • Level 2 simulates a patient with normal ventilatory status • Level 3 simulates a patient hyperventilating SVCC Respiratory Care Programs
  • 81. HCO3- (bicarbonate): SB (standard bicarbonate) AB (actual bicarbonate) SB: the contents of HCO3- of serum of arterial blood in 37-38℃, PaCO2 40mmHg, SaO2 100%. Normal: 22-27mmol/L mean: 24mmol/L AB: The contents of HCO3- in actual condition. In normal person: AB=SB
  • 82. AB and SB are parameters to reflect metabolism, regulated by kidney. Difference of AB-SB can reflect the respiratory affection on serum HCO3- . Respiratory acidosis: AB>SB Respiratory alkalosis: AB<SB Metabolic acidosis: AB=SB<Normal Metabolic alkalosis: AB=SB>Normal
  • 83. 8 Sequential Rules: • Rule #1 – Must know the pH; pH determines whether the primary disorder is an acidosis or an alkalosis • Rule #2 – Must know the PaCO2 and serum HCO3- • Rule #3 – Must be able to establish that the available data (pH, PaCO2, and HCO3-) are consistent
  • 84. Are the data consistent? • The Henderson Equation: H   24   PaCO HCO 2  3
  • 85. Convert +] [H to pH: • Subtract calculated [H+] from 80; this gives the last two digits of a pH beginning with 7 – example: calculated [H+] of 24 converts to pH of (80-24)~7.56 – example: calculated [H+] of 53 converts to pH of (80-53)~7.27 • Refer to table 1 in handout for more precise conversion, or if calculated [H+] exceeds 80
  • 87. Relationship between + +] [H + & pH pH [H ] pH [H ] 7.80 7.75 7.70 7.65 7.60 7.55 7.50 7.45 7.40 7.35 16 18 20 22 25 28 32 35 40 45 7.30 7.25 7.20 7.15 7.10 7.00 6.95 6.90 6.85 6.80 50 56 63 71 79 89 100 112 141 159
  • 88.
  • 89. Simple Acid-Base Disorders: T y p e o f D iso rd er M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis pH  P a C O 2 [H C O 3 ] 
  • 90. Simple Acid-Base Disorders: T y p e o f D iso rd er M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis pH  P a C O 2 [H C O 3 ]  
  • 91. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis  
  • 92. Simple Acid-Base Disorders: T y p e o f D iso rd er T y p e o f D iso rd er pH pH P a C O 2 [H C O 3 ] P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A cid o sis M etab o lic A lk alo sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis      
  • 93. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis   C h ro n ic R esp irato ry A cid o sis   A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis
  • 94. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis    C h ro n ic R esp irato ry A cid o sis    A cu te R esp irato ry A lk alo sis C h ro n ic R esp irato ry A lk alo sis
  • 95. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis   C h ro n ic R esp irato ry A lk alo sis  
  • 96. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis M etab o lic A lk alo sis A cu te R esp irato ry A cid o sis C h ro n ic R esp irato ry A cid o sis A cu te R esp irato ry A lk alo sis    C h ro n ic R esp irato ry A lk alo sis   
  • 97. Simple Acid-Base Disorders: T y p e o f D iso rd er pH P a C O 2 [H C O 3 ] M etab o lic A cid o sis    M etab o lic A lk alo sis    A cu te R esp irato ry A cid o sis    C h ro n ic R esp irato ry A cid o sis    A cu te R esp irato ry A lk alo sis    C h ro n ic R esp irato ry A lk alo sis   
  • 98. Simple Acid-Base Disorders: • The compensatory variable always changes in the SAME DIRECTION as the primarily deranged variable • Compensation is always more pronounced in CHRONIC RESPIRATORY disorders than in acute respiratory disorders
  • 99. 8 Sequential Rules: • Rule #4: – must know if compensation is appropriate – compensation never overshoots • Must have known “rules of thumb” to interpret appropriateness of compensation
  • 100. Rules of Compensation: • Metabolic Acidosis – PaCO2 should fall by 1 to 1.5 mm Hg x the fall in plasma [HCO3] • Metabolic Alkalosis – PaCO2 should rise by .25 to 1 mm Hg x the rise in plasma [HCO3]
  • 101. Rules of Compensation: • Acute Respiratory Acidosis – Plasma [HCO3] should rise by ~1mmole/l for each 10 mm Hg increment in PaCO2 • Chronic Respiratory Acidosis – Plasma [HCO3] should rise by ~4mmoles/l for each 10 mm Hg increment in PaCO2
  • 102. Rules of Compensation: • Acute Respiratory Alkalosis – Plasma [HCO3] should fall by ~1-3 mmole/l for each 10 mm Hg decrement in PaCO2, usually not to less than 18 mmoles/l • Chronic Respiratory Alkalosis – Plasma [HCO3] should fall by ~2-5 mmole/l for each 10 mm Hg decrement in PaCO2, usually not to less than 14 mmoles/l
  • 103. Case #1: • A 24 years old with chronic renal failure presents to ER with history of increasing azotemia, weakness, and lethargy. Exam reveals the patient to be modestly hypertensive, and tachypneic. Labs reveal BUN=100 mg, and Creatinine=8 mg.
  • 104. Case #1: • Steps 1&2: must know pH, PaCO2, HCO3 • pH=7.37, PaCO2=22, and HCO3=12 • Step 3: are the available data consistent? H   24   PaCO HCO 2  3
  • 105. Case #1: • [H+]=44, equates to pH~7.36; data are thus consistent • What is the primary disorder? • “_________Acidosis” • Which variable (PaCO2, HCO3) is deranged in a direction consistent with acidosis? • Primary disorder is “Metabolic Acidosis”
  • 106. Is compensation appropriate? • HCO3 is decreased by 12 mmoles/l • PaCO2 should decrease by 1 to 1.5 times the fall in HCO3; expect PaCO2 to decrease by 12-18 mm Hg or be between 22-28 mm Hg • Since PaCO2 is 22 mm Hg, compensation is appropriate, and the data are consistent with a simple metabolic acidosis with respiratory compensation
  • 107. 8 Sequential Rules: • Rule #5: – If the data are consistent with a simple disorder, it does not guarantee that a simple disorder exists; need to examine the patient’s history • Rule #6: – When compensatory responses do not lie within the accepted range, by definition a combined disorder exists.
  • 108. Case #2: • A 16 year old male with sickle cell anemia, hemochromatosis, & subsequent cirrhosis, presents with a several day history of emesis. At presentation to the pedes ER, he is hypotensive, orthostatic, and confused. • What acid-base disorders might be anticipated based on the above information?
  • 109. Case #3: • 16 yo male with sickle cell anemia, hemochromatosis, & subsequent cirrhosis, and several days of emesis. In the pedes ER, he is hypotensive, orthostatic, and confused. • Emesis-loss of H+ (HCl)-metabolic alkalosis • Orthostatic hypotension-?lactic acidosis • SCD-decreased O2 delivery-?lactic acidosis • Cirrhosis-decreased lactate metabolism
  • 110. Case #3: • • • • What baseline information is available? pH=7.55, PaCO2=66 „lytes: Na+=166, K+=3.0, Cl-=90, HCO3=56 Are the data internally consistent? H   24   PaCO HCO 2  3
  • 111. Case #3: • • • • • [H+]~28, equates to pH~7.55; consistent What is the primary abnormality? “_________ Alkalosis” PaCO2ed, HCO3 ed, therefore……. “Metabolic Alkalosis” presumed due to emesis • Is compensation appropriate?
  • 112. Case #3: • Metabolic Alkalosis – PaCO2 should rise by .25 to 1 mm Hg x the rise in plasma [HCO3] • HCO3 ed by 32; PaCO2 should  by 8-32 • PaCO2 ed by 26, so compensation appears appropriate • What about multiple risk factors for lactic acidosis?
  • 113. Case #3: • • • • • • Could there be a concealed lactic acidosis? What is the anion gap? Na+- (Cl- + HCO3), normally 12-14 Anion gap here is 166 - (90 + 56) = 20 ed anion gap implies metabolic acidosis Combined metabolic alkalosis & metabolic acidosis therefore present
  • 114. 8 Sequential Rules: • Rule #7: Always calculate the anion gap • Often it is the only sign of an occult metabolic acidosis – acidotic patients partially treated with HCO3 – acidotic patients with emesis • May be the only sign of metabolic acidosis “concealed” by concomitant acid-base disorders
  • 115. Causes of  Anion Gap Acidosis: • Endogenous acidosis – Uremia (uncleared organic acids) – Ketoacidosis, Lactic acidosis (increased organic acid production), Rhabdomyolosis • Exogenous acidosis – ingestions: salicylate, iron; paraldehyde use • Other Ingestions: – Methanol toxicity, Ethylene Glycol toxicity
  • 116. Causes of normal Anion Gap Acidosis: • • • • • Diarrhea Isotonic saline infusion Renal tubular acidosis Acetazolamide Ureterocolic shunt
  • 117. Anion Gap: • Based on the concept of electroneutrality; the assumption that the sum of all available cations= the sum of all available anions. Restated as: • Na+ + Unmeasured Cations (UC) = Cl- + HCO3 + Unmeasure Anions (UA); conventionally restated: • Na+-(Cl-+HCO3)=UA-UC=Anion Gap=12 to 14
  • 118. Anion Gap: • Na+-(Cl-+HCO3)=UA-UC • Serum albumin contributes ~1/2 of the total anion equivalency of the “UA” pool. Assuming normal electrolytes, a 1gm/dl decline in serum albumin decreases the anion gap factitiously by 3 mEq/L. Therefore an anion gap of 12 mEq/L is corrected to 17-18 mEq/L when the serum albumin is half of normal; this is an important correction factor in settings of chronic illness or malnourished patients
  • 119. Case #3: • A 3 year old is brought to the pedes ER at ~3am, stuporous and tachypneic. History is remarkable for his parents having cleaned out their medicine cabinet earlier that day. An ABG and electrolytes have been accidentally drawn by the nurse.
  • 120. Case #4: • Available data: pH=7.53, PaCO2=12; Na+=140, K+=3.0, Cl-=106, HCO3=10 • Are the data internally consistent? H   24   PaCO HCO 2  3
  • 121. Case #4: • • • • [H+]~29, so pH~7.51; data consistent What is the primary disturbance? “__________ Alkalosis” Which variable (PaCO2, HCO3) is deranged in a direction consistent with alkalosis? • ed PaCO2, ed HCO3; so “Respiratory Alkalosis”
  • 122. Case #4: • Is compensation appropriate? • Acute respiratory alkalosis – Plasma [HCO3] should fall by ~1-3 mmole/l for each 10 mm Hg decrement in PaCO2, usually not to less than 18 mmoles/l • PaCO2 ed by ~30 mm Hg; HCO3 should fall by 3-9 mmole/l; HCO3  is too great, so superimposed metabolic acidosis
  • 123. Case #4: • What is the anion gap? • 140 - (106 + 10) = 24; elevated anion gap consistent with metabolic acidosis • What is the differential diagnosis? • Combined (true) respiratory alkalosis and metabolic acidosis seen in sepsis, or salicylate intoxication
  • 124. Case #5: • A 5 year old with Bartter‟s Syndrome is brought to clinic, where she collapses. She has recently been febrile, but history is otherwise unremarkable. An ABG and serum electrolytes are obtained: pH=6.9, PaCO2=81; Na+=142, K+=2.8, Cl-=87, HCO3=16
  • 125. Case #5: • Are the data consistent? H   24   PaCO HCO 2  3 • [H+]=122, pH~6.9; data are consistent
  • 126. Case #5: • What is the primary disturbance? • “_________ Acidosis” • Which variable (PaCO2, HCO3) is deranged in a direction consistent with acidosis? • Both; pick most abnormal value-• “Respiratory Acidosis” • Is compensation appropriate?
  • 127. Case #5: • Acute Respiratory Acidosis – Plasma [HCO3] should rise by ~1mmole/l for each 10 mm Hg increment in PaCO2 • Since HCO3 is inappropriately depressed, compensation is not appropriate, and there is a concomitant metabolic acidosis as well • What is the anion gap? • AG=39, confirms metabolic acidosis
  • 128. Case #5: • Combined Respiratory Acidosis and Metabolic Acidosis; are there other disorders present? • What about the dx of Bartter‟s Syndrome? • Bartter‟s Syndrome characterized by hypokalemic metabolic alkalosis • Does this patient have a concealed metabolic alkalosis?
  • 129. Case #5: • Anion gap is 39, or 25-27 greater than normal • Typically, increases in anion gap correlate with decreases in HCO3 • Assuming a 1:1 relationship, as anion gap increases by 25, HCO3 should fall by 25 • Starting HCO3 must have been 16 + 25 = 41
  • 130. Case #5: • Therefore, starting HCO3 was ~41 mmol/l, consistent with expected chronic metabolic alkalosis. This metabolic alkalosis was “concealed” by the supervening profound metabolic and respiratory acidoses associated with her arrest event. • Final diagnosis: Metabolic alkalosis, metabolic acidosis, & respiratory acidosis
  • 131. 8 Sequential Rules; Rule #8 • Rule #8: Mixed Acid-Base Disorders • Coexistant metabolic acidosis and metabolic alkalosis may occur. Always check the change in the anion gap vs. decrement in bicarbonate to rule out a concealed metabolic disorder.
  • 132. Case #6: • A 3 year old toddler is brought to the ER at 3 am after being found unarousable on his bedroom floor, with urinary incontinence. EMS monitoring at the scene revealed sinus bradycardia. One amp of D50W and 5 mg of naloxone were given IV without response. Vital signs are stable; respiratory effort is regular, but tachypneic. He is acyanotic.
  • 133. Case #6: • Initial lab studies (lytes, ABG & urine tox screen) are sent. Initial dextrostick is >800. • Initial available data are: • Na+=154, K=5.6, Cl=106, HCO3=5, BUN=6 creatinine=1.7, glucose=804, PO4=12.3, Ca++=9.8, NH4=160, serum osms=517 • pH=6.80, PaCO2=33, PaO2=298
  • 134. Case #6: • • • • • • • What is the primary disturbance? ________ Acidosis Metabolic Acidosis Is compensation appropriate? No; PaCO2 level is inappropriately high Are other disorders present? Respiratory acidosis (due to evolving coma)
  • 135. Case #6: • What is our differential thus far? – Anion gap vs. non-anion gap metabolic acidosis – DKA, lactic acidosis, renal failure, ingestion • The urine tox screen comes back negative – What does urine tox screen actually screen for? • The patient‟s IV falls out. He then has a seizure, is incontinent of urine, and fills the specimen bag you placed on ER arrival.
  • 136. Case #6: • What is the calculated serum osmolality, and does an osmolal gap exist? • 2(Na) + BUN/2.8 + Glucose/18 – Calculated=355, Measured=517 • What is the most likely diagnosis? • How can this be confirmed definitively? – Review of urinalysis – Serum ethylene glycol level
  • 137. Case #6: Methanol, ethylene glycol ethyl alcohol, isopropyl alcohol Anion gap metabolic acidosis Osmolal gap
  • 138. Gap-Gap *AG excess/HCO3 deficit= (Measured AG-12)/ (24-measured HCO3) *Ratio <1 in presence of high AG acidosis means coexistance of normal AG metabolic acidosis *Ratio >1 in presence of high AG acidosis means coexistance of metabolic alkalosis